Immediate Impact

66 standout
Sub-graph 1 of 24

Citing Papers

FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond
2024 Standout
1 intermediate paper

Works of Anders Amilon being referenced

Identification of three novelFGF16mutations in X‐linked recessive fusion of the fourth and fifth metacarpals and possible correlation with heart disease
2014

Author Peers

Author Last Decade Papers Cites
Anders Amilon 590 24 59 173 123 13 671
S. Ramamurthy 527 5 53 205 175 22 711
Sarah J. Madison 604 2 54 208 138 27 708
Scott A. Lang 388 5 13 140 188 25 680
Guðmundur Björnsson 301 7 206 176 69 9 673
Christoph Harms 459 5 21 104 113 19 843
Carolyne Pehora 343 8 45 227 56 27 609
David B. Auyong 718 3 27 106 125 30 801
Matthew S. Abrahams 645 12 11 138 145 11 693
Özgür Dikme 226 6 156 101 51 10 654
Arun Prasad 363 5 30 195 76 16 734

All Works

Loading papers...

Rankless by CCL
2026